Exagen Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Exagen Inc. on September 23, 2019. The filing documents the closing of the Company's Initial Public Offering (IPO) and the concurrent adoption of amended corporate governance documents.
Key Financial Metrics
- Capital Raised: The Company sold 4,140,000 shares of common stock, including the full exercise of the underwriters' option to purchase 540,000 additional shares.
- Offering Price: $14.00 per share.
- Gross Proceeds: $58.0 million (before deducting underwriting discounts, commissions, and offering expenses).
- Other Metrics: The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The primary material change is the transition from a private to a public company via the IPO. Additionally, the Company amended its Certificate of Incorporation and Bylaws to:
- Increase authorized common stock to 200,000,000 shares.
- Eliminate references to convertible preferred stock and authorize 10,000,000 shares of undesignated preferred stock.
- Establish a classified board of directors with staggered three-year terms.
- Require a two-thirds vote to remove directors for cause.
- Eliminate stockholder action by written consent.
- Designate the Court of Chancery of the State of Delaware as the exclusive forum for certain legal actions.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future performance, or specific risk factors beyond the standard legal provisions regarding the exclusive forum for litigation. The filing focuses strictly on the mechanics of the IPO closing and corporate restructuring.
Investor Verification Checklist
- Verify the net proceeds after deducting underwriting discounts and offering expenses.
- Review the full text of the Amended and Restated Certificate of Incorporation (Exhibit 3.1) and Bylaws (Exhibit 3.2) for specific governance restrictions.
- Confirm the use of proceeds as detailed in the Company's Registration Statement (S-1).
- Check for any lock-up agreements or restrictions on the sale of shares by existing stockholders.